The essential role of radiation therapy in securing locoregional control of merkel cell carcinoma
William H. Morrison(The University of Texas MD Anderson Cancer Center), Helmuth Goepfert(The University of Texas MD Anderson Cancer Center), Charles D. Wendt(The University of Texas MD Anderson Cancer Center), Elvio G. Silva(The University of Texas MD Anderson Cancer Center), Lester J. Peters(Peter MacCallum Cancer Centre), K. Kian Ang(Third Affiliated Hospital of Southern Medical University)
International Journal of Radiation Oncology*Biology*Physics
September 1, 1990
Cited by 212
Related Papers
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|1990|1.4k
Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
|International Journal of Radiation Oncology*Biology*Physics|1982|842
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
|Journal of Clinical Oncology|2014|830
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741